Health Promotion and Human Behavior

kao
Toshiaki A. Furukawa, MD, PhD, Professor  btn

Department of Health Promotion and Human Behavior promotes pragmatic and empirical research on behaviors and cognitions that bear on disease and health of humankind. Its two vehicles of research consist of cognitive-behavior therapy (CBT) and clinical epidemiology (evidence-based medicine: EBM). Students are expected to learn how to interpret and apply evidence to clinical problems in their own fields, plan and execute clinical research to answer questions not yet covered in the current literature, and ultimately to contribute to better clinical practices in the world.

Research and Education

The research themes in the Department currently include:
1.In the field of EBM,
1.1. Randomized controlled trials
1.2. Network meta-analyses, Individual patient (network) meta-analysis, Component network meta-analysis
1.3. Meta-epidmiological studies
1.4. Research and development of new methods to translate evidence into clinical practices, applying epidemiology, statistics and psychometrics.
2.In the field of CBT,
2.1. Smartphone-based CBT
2.2. CBT programs for patients with physical diseases

Recent Publications

  1. Cipriani A, Furukawa TA, Salanti G, et al (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 391, 1357-1366.
  2. Nikolakopoulou A, Mavridis D, Furukawa TA, et al (2018) Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study. BMJ, 360, k585.
  3. Kato T, Furukawa TA, Mantani A, et al (2018) Optimising first- and second-line treatment strategies for untreated major depressive disorder – the SUND study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial. BMC Medicine, 16, 103.
  4. Furukawa TA, Cipriani A, Atkinson LZ, et al (2016) Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry, 3, 1059-1066.
  5. Furukawa TA, Levine SZ, Tanaka S, et al (2015) Initial severity of schizophrenia and efficacy of antipsychotics: Participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry, 72, 14-21.

Health Promotion and Human Behavior

Professor: Toshiaki A. Furukawa, MD, PhD
Associate Professor: Norio Watanabe, MD, PhD
TEL: 075-753-9491
FAX: 075-753-4641
Email: cbm.kusph@gmail.com
URL:http://ebmh.med.kyoto-u.ac.jp